Oncimmune Holdings (ONC) RNS Announcements

Add to Alert list
Date Time Source Announcement
20 May 2022 12:11 PM
RNS
Holding(s) in Company
18 May 2022 11:46 AM
RNS
Holding(s) in Company
05 May 2022 05:32 PM
RNS
Holding(s) in Company
03 May 2022 06:10 PM
RNS
Holding(s) in Company
26 Apr 2022 04:26 PM
RNS
Holding(s) in Company
21 Apr 2022 07:00 AM
RNS
Queen's Award for Enterprise in Innovation 2022
14 Apr 2022 12:24 PM
RNS
Exercise of Options, PDMR Dealing and TVR
08 Apr 2022 07:00 AM
RNS
Two further ImmunoINSIGHTS contracts signed
04 Apr 2022 02:43 PM
RNS
Holding(s) in Company
29 Mar 2022 04:46 PM
RNS
Exercise of Options, PDMR Dealing and TVR
18 Mar 2022 03:01 PM
RNS
Holding(s) in Company
16 Mar 2022 07:00 AM
RNS
Block Listing Six Monthly Return
15 Mar 2022 07:00 AM
RNS
Exercise of Warrants and Total Voting Rights
09 Mar 2022 04:08 PM
RNS
Holding(s) in Company
07 Mar 2022 02:10 PM
RNS
PDMR Dealing
07 Mar 2022 07:00 AM
RNS
Follow-on contract to validate previous profiling
04 Mar 2022 07:00 AM
RNS
ImmunoINSIGHTS contract signed with global pharma
01 Mar 2022 07:00 AM
RNS
ImmunoINSIGHTS and Synexa partnership
28 Feb 2022 07:05 AM
RNS
Interim Results
28 Feb 2022 07:00 AM
RNS
Contract signed with Verily Life Sciences
25 Feb 2022 07:00 AM
RNS
Notice of Half Year Results
21 Feb 2022 03:14 PM
RNS
Holding(s) in Company
17 Feb 2022 07:00 AM
RNS
EarlyCDT Lung approved and adopted in Aragon Spain
15 Feb 2022 07:00 AM
RNS
ImmunoINSIGHTS commercial update
31 Dec 2021 07:00 AM
RNS
Results from COVID-19 autoantibody profiling panel
24 Dec 2021 07:00 AM
RNS
PDMR Dealing
22 Dec 2021 11:10 AM
RNS
Grant of Options and PDMR Dealing
21 Dec 2021 11:34 AM
RNS
PDMR Dealing
21 Dec 2021 07:00 AM
RNS
ImmunoINSIGHTS commercial update
20 Dec 2021 03:13 PM
RNS
Total Voting Rights
07 Dec 2021 07:00 AM
RNS
Commercial momentum in ImmunoINSIGHTS
26 Nov 2021 04:41 PM
RNS
Second Price Monitoring Extn
26 Nov 2021 04:36 PM
RNS
Price Monitoring Extension
26 Nov 2021 10:36 AM
RNS
Results of Annual General Meeting
03 Nov 2021 07:00 AM
RNS
Notice of AGM and posting of Annual Report
02 Nov 2021 07:00 AM
RNS
Full year results and progress update
02 Nov 2021 07:00 AM
RNS
Change of Adviser
27 Oct 2021 04:35 PM
RNS
Price Monitoring Extension
25 Oct 2021 04:40 PM
RNS
Second Price Monitoring Extn
25 Oct 2021 04:35 PM
RNS
Price Monitoring Extension
25 Oct 2021 07:00 AM
RNS
Notice of Full Year results
20 Sep 2021 07:00 AM
RNS
Agreement with pharma company to profile patients
15 Sep 2021 11:08 AM
RNS
Block Listing Six Monthly Return
23 Aug 2021 07:00 AM
RNS
Three-year follow-up data for the ECLS trial
23 Jul 2021 07:00 AM
RNS
Agreement signed with major cancer center
22 Jul 2021 07:00 AM
RNS
Validation of ImmunoINSIGHTS service in COVID-19
01 Jul 2021 07:00 AM
RNS
Total Voting Rights
08 Jun 2021 07:00 AM
RNS
Full Year Trading Update
28 May 2021 07:30 AM
RNS
Notice of FY21 Trading Update
05 May 2021 07:03 AM
RNS
Return of China Rights to EarlyCDT
UK 100

Latest directors dealings